UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia

NCT07530380 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

AIHA - Warm Autoimmune Hemolytic Anemia
UCART

Interventions

BIOLOGICAL: QT-219C Cell Injection

Sponsor

The Second Hospital of Anhui Medical University